Introduction
============

Neuroblastoma (NB) is an embryological malignant disease primarily affecting the adrenal medulla; however, NBs may occur in the abdomen, chest, pelvis and other areas where nerves terminate ([@b1-mmr-20-04-3475]). NB is among the most common types of pediatric solid tumors, and \~90% of NB cases occur in children \<5 years of age with a median age of 18 months ([@b2-mmr-20-04-3475]). NB accounts for \~8% of total pediatric malignancies and \~15% of total cancer mortalities ([@b3-mmr-20-04-3475]). The International Neuroblastoma Staging System defined four stages for NB ([@b4-mmr-20-04-3475]), and the survival rate is determined by the age and the disease stage of patients with NB ([@b3-mmr-20-04-3475]). Although multimodal therapies have been developed to improve the survival rate of patients with NB, the overall survival rate remains \<40%, and patients with NB at stage four have a five-year survival rate of 30--35% ([@b5-mmr-20-04-3475]). Therefore, early diagnosis and pathogenesis of NB are important factors for improving the survival rate of patients with NB.

A number of potential markers for early diagnosis and therapeutic targets of NB have been investigated. The neuropeptide Y (NPY), a sympathetic neurotransmitter expressed in the central nervous system, was significantly overexpressed in NB tumor tissues of a TH-MYCN mouse model and its increased expression level was associated with poor survival, tumor metastasis and relapse of NB ([@b6-mmr-20-04-3475]). Astrocyte elevated gene-1, which encodes for metadherin, was upregulated in NB and promotes NB cell proliferation by activating the phosphatidylinositol-3-kinase/AKT serine/threonine kinase 1 signaling pathway ([@b7-mmr-20-04-3475]). Pim 1 proto-oncogene, serine/threonine kinase (PIM1), PIM2 and PIM3 are proto-oncogenes encoding for Ser/Thr protein kinases; the high expressions of these genes were significantly correlated with poor overall survival of patients with NB ([@b8-mmr-20-04-3475]). Galinski *et al* ([@b9-mmr-20-04-3475]) suggested a novel therapeutic biomarker, exportin-1 (XPO1), for patients with NB, and demonstrated that high expression of XPO1 in patients with NB was associated with poor outcomes. Additionally, downregulation of bone morphogenetic protein receptor 2 increased the cell growth and clonogenicity of NB cells ([@b10-mmr-20-04-3475]). A previous study demonstrated that neuropilin 1 may be a promising diagnostic biomarker for NB, and its knockdown increased the migration and invasion of SK-N-AS NB cells ([@b11-mmr-20-04-3475]). In contrast, knockdown of solute carrier family 39 member 8 inhibited the progression and metastasis of NB ([@b12-mmr-20-04-3475]). Transcription factors (TFs) serve important roles in the initiation and progression of NB. POU class 4 homeobox 2 (POU4F2) TF regulates the growth, invasive capacity and proliferation of NB cells, and decreased expression of POU4F2 may inhibit these effects ([@b13-mmr-20-04-3475]). In 2010, Souzaki *et al* ([@b14-mmr-20-04-3475]) suggested that increased expression levels of sonic hedgehog, GLI family zinc finger 1 and patched 1 are involved in activating the hedgehog signaling pathway, and it was suggested that activation of this pathway is involved in NB differentiation ([@b14-mmr-20-04-3475]). Although numerous previous studies identified potential markers and examined the mechanisms associated with NB development, the molecular mechanisms underlying NB progression remain unclear.

In the present study, the GSE78061 dataset from Hart *et al* ([@b15-mmr-20-04-3475]) was downloaded from the Gene Expression Omnibus (GEO) database, to conduct a bioinformatics analysis. The GSE78061 dataset was analyzed to identify differentially expressed genes (DEGs) between NB cell lines and normal retinal pigment epithelial (RPE) cells. Furthermore, the protein-protein interactions (PPIs) of the proteins encoded by DEGs were investigated, in order to examine the TFs regulating the DEGs, and to investigate the molecular mechanisms underlying NB. Additionally, the present study may provide novel diagnostic and therapeutic markers for NB.

Materials and methods
=====================

### Microarray data

The GSE78061 dataset ([@b15-mmr-20-04-3475]) used in the present study was downloaded from GEO ([www.ncbi.nlm.nih.gov/geo/](www.ncbi.nlm.nih.gov/geo/)), based on the Affymetrix human gene 1.0 ST array (Thermo Fisher Scientific, Inc., Waltham, MA, USA). Expression data from 25 human NB cell lines and four RPE cell lines were analyzed in the GSE78061 dataset.

### Data preprocessing

Raw expression data in CEL format were downloaded and the Oligo package in R (version 3.4.1; [CRAN.R-project.org/bin/windows/base](CRAN.R-project.org/bin/windows/base)) was used to read the chip data ([@b16-mmr-20-04-3475]). The expression data of all samples were preprocessed and normalized using the robust multi-array average method ([@b17-mmr-20-04-3475]), which included background-adjusted quantile normalization, log-transformed perfect match values and summarization.

### DEGs and hierarchical cluster analyses

The probe levels were extracted from the expression matrix following data preprocessing. The linear models for microarray data (limma; version 3.26.9; [www.bioconductor.org/packages/3.2/bioc/html/limma.html](www.bioconductor.org/packages/3.2/bioc/html/limma.html)) package in R was applied to screen for DEGs between NB samples and RPE samples ([@b18-mmr-20-04-3475]). The threshold values for identifying DEGs were defined as adj.p.val \<0.01 and \|log~2~ fold-change (FC) \|\>2. Additionally, the pheatmap package was used (version 1.0.8; [cran.r-project.org/web/packages/pheatmap/index.html](cran.r-project.org/web/packages/pheatmap/index.html)) in R to draw two-dimensional clustering heatmaps based on the expression levels of the identified DEGs.

### Functional and pathway enrichment analyses

The Gene Ontology (GO; [www.geneontology.org](www.geneontology.org)) database provides functional categorization and annotations of biological process (BP), molecular function (MF) and cellular component (CC) for large-scale transcriptomic data ([@b19-mmr-20-04-3475]). The Kyoto Encyclopedia of Genes and Genomes (KEGG; [www.genome.jp/kegg](www.genome.jp/kegg)) is a comprehensive database that integrates genomic, chemical and systemic information to define the function of genes or proteins involved in various metabolic and regulatory pathways ([@b20-mmr-20-04-3475]). Additionally, the Database for Annotation, Visualization and Integrated Discovery (DAVID; version 6.8; [david.abcc.ncifcrf.gov](david.abcc.ncifcrf.gov)) ([@b21-mmr-20-04-3475]) is a tool for performing GO and KEGG pathway enrichment analyses. In the present study, DAVID was used to perform functional enrichment analysis for upregulated and downregulated genes. The significantly enriched results were selected with the following cutoffs: Enriched gene count ≥2 and P-value \<0.01.

### PPI network and submodule analyses

The Search Tool for the Retrieval of Interacting Genes (STRING; [string-db.org/](string-db.org/)) ([@b22-mmr-20-04-3475]) is a database that integrates functional interactions among proteins in numerous organisms. The weighted protein interactions provide information associated with functional linkages between proteins and genomic associations among gene products. In the present study, the STRING database was used to investigate interacting proteins encoded by DEGs and the default value of the combined score \>0.4 was set as the criteria for selecting significant interactions. Cytoscape software ([www.cytoscape.org/](www.cytoscape.org/); version 3.3.0) is a visualization tool for analyzing molecular networks ([@b23-mmr-20-04-3475]), in which nodes represent proteins, and edges connecting the nodes indicate their associations. Key nodes in the PPI network were obtained based on the ranks of their connectivity degrees.

In the PPI network, the distances between two nodes are associated with their function and nodes tend to cluster together based on similar function. Therefore, submodule analysis is an effective strategy for predicting protein function. The Molecular Complex Detection (MCODE, version 1.4.2) tool was used to perform submodule analysis for the PPI network ([@b24-mmr-20-04-3475]).

### TF prediction and construction of transcriptional regulation network

Transcriptional Regulatory Relationships Unravelled by Sentence-based Text-mining (TRRUST; version 2; [www.grnpedia.org/trrust](www.grnpedia.org/trrust)) is a database that contains 8,444 and 6,552 TF-target regulatory associations of 800 human TFs and 828 mouse TFs, respectively. The TRRUST database draws from 11,237 PubMed articles and represents small-scale experimental studies of transcriptional regulation ([@b25-mmr-20-04-3475]). The TRRUST database was used to identify the TFs among the DEGs and the regulatory associations between the TFs and their target genes. Subsequently, the predicted target genes among the DEGs were screened, and a transcriptional regulation network was constructed using Cytoscape software.

### Validation of gene expression by reverse transcription-quantitative polymerase chain reaction (RT-qPCR)

RT-qPCR analysis was performed to detect the gene expression levels of numerous DEGs predicted to be associated with human NB. hTERT RPE-1 cells (Jennio Bioech Co., Ltd., Guangzhou, China) were cultured in RPMI-1640 medium (Gibco; Thermo Fisher Scientific, Inc.), and SH-SY5Y cells (cat. no. SCSP-5014; Stem Cell Bank, Chinese Academy of Sciences, Shanghai, China) were cultured in Dulbecco\'s modified Eagle\'s medium/nutrient mixture F-12 (Gibco; Thermo Fisher Scientific, Inc). Both cells lines were cultured at 37°C under a humidified 5% CO~2~ atmosphere. Total RNA was extracted using TRIzol^®^ reagent (Invitrogen; Thermo Fisher Scientific, Inc.), and RNA was reverse-transcribed using PrimeScript RT master mix (Takara Bio, Inc., Otsu, Japan) for cDNA synthesis at 37°C for 60 min, followed by 37°C for 5s. Following cDNA synthesis, qPCR was conducted using Power SYBR Green PCR master mix (Thermo Fisher Scientific, Inc.). The RCR thermocycling conditions were as follows: 50°C for 3 min, 40 cycles of (95°C for 3 min, 95°C for 10s, and 60°C for 30s), followed by 72°C for 5 min. GAPDH was used as the reference gene. Primer sequences are listed in [Table I](#tI-mmr-20-04-3475){ref-type="table"}. Relative gene expression was calculated using the 2^−ΔΔCq^ method ([@b26-mmr-20-04-3475]). All experiments were repeated three times.

### Statistical analysis

All results are presented as the mean ± standard error. Differences between groups were evaluated by Student\'s t-test. Statistical analysis of differences between groups was performed using SPSS software (version 22; IBM Corp., Armonk, NY, USA) and P\<0.05 was considered to indicate a statistically significant difference. Graphs were obtained using Prism (version 5; GraphPad Software, Inc., La Jolla, CA, USA).

Results
=======

### Identification of DEGs and hierarchical cluster analysis

Using the cutoff criteria of adj.p.val \<0.01 and \|log~2~ FC\|\>2, 928 DEGs were identified in human NB cell lines compared with RPE cell lines. Among the 928 DEGs identified, 386 DEGs were upregulated and 542 DEGs were downregulated. The number of downregulated DEGs was 1.4-fold increase compared with upregulated DEGs. Additionally, hierarchy cluster analysis suggested that the DEGs clustered according to the two types of cell lines based on their expression profiles, suggesting that the DEGs may be used for further analyses ([Fig. 1](#f1-mmr-20-04-3475){ref-type="fig"}).

### Functional enrichment analysis of DEGs

DEGs were analyzed using DAVID software to identify significant KEGG pathways and GO terms in the category of BP, CC and MF. The top five GO terms within BP, CC and MF, and the top five KEGG pathways for upregulated and downregulated DEGs are presented in [Table II](#tII-mmr-20-04-3475){ref-type="table"} and in [Fig. 2](#f2-mmr-20-04-3475){ref-type="fig"}. Upregulated genes were significantly enriched in 'neuron migration' \[GO term: GO:0001764; including GATA binding protein 2 (GATA2), paired like homeobox 2B (PHOX2B) and tubulin β 2B class IIb (TUBB2B)\] and 'dopaminergic synapse' signaling pathways \[KEGG pathway: hsa04728; including mitogen-activated protein kinase 10 (MAPK10), dopa decarboxylase (DDC) and G protein subunit γ 2 (GNG2)\]. Although 'nervous system development' was more significant, there were more hub genes in PPI network enriched in 'neuron migration' and the P-values of these two terms were very close. Therefore, 'neuron migration' was selected for further discussion. Besides, we choose 'dopaminergic synapse' pathway to discuss due to this pathway theoretically may be more associated with the development of NB and can be explained by several appropriate article than 'alcoholism' pathway and its significant P-value was only next to 'alcoholism'. The majority of the downregulated DEGs were primarily involved in functions associated with 'focal adhesion' \[GO term: GO:0005925; including integrin subunit α 2 (ITGA2), ITGA3, ITGA4 and ITGA5\] and 'proteoglycans in cancer' (KEGG pathway: hsa05205; ITGA2, ITGB5, CD44 molecule, ITGA5 and thrombospondin 1). Based on the results, 'cell surface' was more significant and its meaning was broader than that of 'focal adhesion'. What\' more, the majority of nodes in the following module network belonged to the integrin α and β chain family, which were also enriched in this pathway.

### PPI network analysis

By analyzing the upregulated DEGs with the STRING database, a PPI network of upregulated DEGs containing 210 nodes and 346 edges was obtained ([Fig. 3](#f3-mmr-20-04-3475){ref-type="fig"}), whereas, 374 nodes and 1,389 edges were involved in the PPI network of downregulated DEGs ([Fig. 4](#f4-mmr-20-04-3475){ref-type="fig"}). Based on the connectivity degree among the nodes, the top 20 nodes in the upregulated and downregulated PPI networks are listed in [Table III](#tIII-mmr-20-04-3475){ref-type="table"}, including MAPK10, TUBB2B, RAS like family 11 member B (RASL11B) and ITGA2.

### Module analysis

Using a cutoff of score \>10, the module analysis demonstrated that only one submodule (submodule 1) was obtained from the downregulated PPI network, whereas no submodule from the upregulated PPI network was obtained. The submodule 1 contained 13 nodes and 77 interactions ([Fig. 5](#f5-mmr-20-04-3475){ref-type="fig"}). Notably, the majority of nodes in this module belong to the integrin α and β chain family.

### TF prediction and regulatory network analysis

The DEGs were analyzed using the TRRUST database. Subsequently, 23 DEGs were identified to be TFs. A TF-target regulatory network consisting of 73 nodes (23 TFs and 50 DEGs) and 52 interaction associations, such as PHOX2B-ALK was constructed ([Fig. 6](#f6-mmr-20-04-3475){ref-type="fig"}). The top 20 nodes with high degrees are presented in [Table IV](#tIV-mmr-20-04-3475){ref-type="table"} and include transcription factor AP-2 α, melanocyte inducing transcription factor, SMAD family member 3 (SMAD3), runt related transcription factor 1 and PHOX2B. Notably, SMAD3 and PHOX2B belong to the top 20 DEGs in the PPI network. Additionally, the number of downregulated TFs was higher compared with upregulated TFs.

### Validation of gene expression

RT-qPCR was conducted to test the expressions of DEGs. A total of four DEGs were validated: ITGA2, MAPK10, TUBB2B and RASL11B, which have not previously been associated with NB. Compared with hTERT-RPE cells, MAPK10, TUBB2B and RASL11B exhibited a significantly increased expression level in SH-SY5Y cells ([Fig. 7A-C](#f7-mmr-20-04-3475){ref-type="fig"}). In contrast, the mRNA expression level of ITGA2 was decreased in human SH-SY5Y cells ([Fig. 7D](#f7-mmr-20-04-3475){ref-type="fig"}) compared with hTERT-RPE cells. Notably, the RT-qPCR results confirmed the bioinformatics analysis of DEGs in the GSE78061 dataset.

Discussion
==========

In the present study, a set of 928 DEGs was identified in NB cell lines compared with RPE cells lines, 386 DEGs were upregulated and 542 DEGs were downregulated. Upregulated DEGs were significantly associated with 'neuron migration' (including PHOX2B and TUBB2B) and 'dopaminergic synapse' signaling pathways (including MAPK10, DDC and GNG2). The majority of downregulated DEGs were primarily involved in 'focal adhesion' (including ITGA2 and ITGA3). Additionally, the DEGs MAPK10, DDC, GNG2, PHOX2B, TUBB2B, RASL11B, and ITGA2 were highlighted in the PPI networks. Furthermore, based on regulatory associations reported in the TRRUST database, PHOX2B was predicted to function as a TF upstream of ALK in the regulatory network. The upregulation of MAPK10, TUBB2B and RASL11B, and the downregulation of ITGA2 were detected by RT-qPCR in NB SH-SY5Y cells, consistent with the present bioinformatics analysis.

In the present study, a number of hub genes, including MAPK10, DDC and GNG2, belonging to the upregulated PPI networks, were predicted to be involved in the 'dopaminergic synapse' signaling pathway. The majority of human NB cell lines, including the SK-N-AS cell line, are dopaminergic NB cells and exhibit characteristics of dopaminergic neurons ([@b27-mmr-20-04-3475]). Additionally, \~80% of patients diagnosed with NB exhibit increased expression levels of catecholamine and its metabolites, including dopamine and epinephrine, making these molecules promising tumor markers for diagnosing NB ([@b28-mmr-20-04-3475]). Therefore, alterations in the dopamine expression levels mediated by its associated signaling pathway may serve an important role in NB development.

Similarly, *DDC* encodes for an enzyme associated with dopamine synthesis and its expression was demonstrated to be significantly increased in patients with NB ([@b29-mmr-20-04-3475]). Phospholipase Cη2 (PLCH2) belongs to the PLC-η family, and is part of a crucial intracellular signaling system associated with neurotransmitter signal transduction, synapse formation and neuronal network formation; however it is additionally involved in the development of NB and other central nervous system-associated tumors ([@b30-mmr-20-04-3475]). Notably, a previous study suggested that PLCH2 was activated by GNG2 ([@b31-mmr-20-04-3475]), and GNG2 was expressed in the fetal tissues, adrenal gland and brain, regulating a series of intracellular effectors, including ion channels and adenylyl cyclase ([@b32-mmr-20-04-3475]), which were previously associated with NB ([@b33-mmr-20-04-3475],[@b34-mmr-20-04-3475]). Therefore, the present results, suggesting that DDC and GNG2 were associated with NB, are consistent with the results of previous studies.

Additionally, MAPK is a member of the serine/threonine protein kinase family and serves crucial roles in regulating neuronal processes at the cellular level, including synaptic transmission, morphological differentiation and survival ([@b35-mmr-20-04-3475]). Furthermore, Morón *et al* ([@b36-mmr-20-04-3475]) suggested that MAPK regulated dopamine transporters, modulating the concentration of dopamine in the extracellular space. Furthermore, a previous study demonstrated that MAPK10 was associated with the development of cancer ([@b37-mmr-20-04-3475]). Notably, MAPK10 and MAPK9 serve important roles in the death of dopamine neurons of the substantia nigra ([@b38-mmr-20-04-3475]). Similarly, a previous study demonstrated that activation of the MAPK/Jun proto-oncogene (Jun) signaling pathway induced apoptosis in SK-N-SH NB cells by regulating the targets of the adaptor related protein complex 1 complex ([@b39-mmr-20-04-3475]). MAPK10, as a MAPK family member, is additionally involved in the MAPK/Jun signaling pathway. Therefore, MAPK10 may be associated with the progression of NB by serving a role in the dopaminergic synapse and MAPK/Jun signaling pathways. As expected, the expression level of MAPK10 was significantly higher in human NB SH-SY5Y cell lines compared with hTERT-RPE cell lines.

In the present study, it was identified that TUBB2B and RASL11B were significantly upregulated in human NB SH-SY5Y cells. TUBB2B, a principal component of microtubules, is synthesized in axons and is involved in neuronal migration ([@b40-mmr-20-04-3475]). TUBB2B served an essential role in the neural development system and served as a primary neuron marker ([@b41-mmr-20-04-3475]). TUBB2B was identified to be upregulated in the brain cortex tissues of a microtubule associated protein τ (MAPT) transgenic mouse model of Alzheimer\'s disease, suggesting an interaction between MAPT and TUBB2B ([@b42-mmr-20-04-3475]). Notably, hyperphosphorylated MAPT during mitosis is associated with aberrant cell-cycle-dependent kinase activity in the NB cell line SH-SY5Y ([@b43-mmr-20-04-3475]). Therefore, in the present study it was hypothesized that the dysregulation of TUBB2B may be responsible for aberrant neuronal migration and abnormal cell cycle during the development of NB. RASL11B belongs to the small GTPase family and Ras subfamily, and serves as a tumor suppressor gene ([@b44-mmr-20-04-3475]). Additionally, RASL11B was demonstrated to be associated with inflammation and cancer through involvement of transforming growth factor-β1-mediated processes ([@b45-mmr-20-04-3475]). Therefore, RASL11B may be associated with the development of NB. However, further studies are required to investigate its molecular mechanism in NB.

In the TF-target regulatory network, a regulatory association between PHOX2B (upregulated DEG) and anaplastic lymphoma receptor tyrosine kinase (ALK; upregulated DEG) was predicted. Upregulation of PHOX2B is associated with MYCN proto-oncogene, bHLH transcription factor (MYCN), and it was demonstrated to contribute to NB cell proliferation ([@b46-mmr-20-04-3475]). Additionally, upregulation of MYCN is a primary cause of NB progression ([@b46-mmr-20-04-3475]). Notably, Bachetti *et al* ([@b47-mmr-20-04-3475]) identified a correlation between the expression levels of PHOX2B and ALK, by performing small interfering RNA silencing and overexpression experiments. In contrast, ITGA2, which exhibited the highest connectivity degree in the downregulated PPI network, was predicted to be associated with NB. ITGA2 is a member of the cell adhesion receptor family and is crucial for the cell proliferation, metastasis and apoptosis of solid tumors ([@b48-mmr-20-04-3475]). It has been suggested that decreased expression levels of ITAG2 and ITAG3 are inversely correlated with MYCN expression in NB cell lines ([@b49-mmr-20-04-3475]). The present results suggested that ITGA2 and ITGA3 which were present in the GO terms of 'extracellular matrix' and 'focal adhesion' pathways, were significantly downregulated in NB cell lines. Additionally, the present experimental data demonstrated that ITGA2 expression was significantly decreased in SH-SY5Y NB cells. Therefore, PHOX2B, ALK, ITGA2 and ITGA3 may be useful therapeutic targets for NB.

In the present study, although numerous genes were selected, only a limited number of genes (including MAPK10, DDC, GNG2, PHOX2B, TUBB2B and RASL11B) were discussed due to the fact that multiple genes identified in the present analysis \[including GATA3, Microtubule-associated protein 2 (MAP2), Chromogranin A (CHGA) and NPY\] have been previously observed to be associated with the development of NB. GATA3 serves a crucial role in the regulation of cell differentiation and proliferation of SK-N-SH NB cells ([@b50-mmr-20-04-3475]). MAP2 synthesis is increased in NB2a cells, which exhibit dendritic properties in terms of morphology and preferential distribution of MAP2 ([@b51-mmr-20-04-3475]). A previous study demonstrated that CHGA and NPY serve as NB tumor gene markers and are involved in the metastasis of NB cells ([@b52-mmr-20-04-3475]). Notably, these previous findings supported the results of the present study.

However, there were numerous limitations of the present study. Due to the low incidence of NB and the limited possibilities of hospitals in sharing tissues of patients, there were not enough NB tissue samples to be collected in a short-term, in order to perform gene expression validation. Furthermore, NB originates from sympathetic ganglia near the spinal cord and within the adrenal medulla ([@b53-mmr-20-04-3475]). However, hTERT-RPE cells are not part of this tissue, thus hTERT-RPE cells are not the optimal control. This cell line was selected as control cells in the GSE78061 dataset and no appropriate alternative cells were considered. The hTERT-RPE cell line was selected as the control for experiment validation, in order to be consistent with the GSE78061 dataset. Furthermore, due to insufficient funds, the experimental validation was not conducted in additional cell lines. The present findings require confirmation using additional cell lines and the analysis of a sufficient number of NB and normal tissue or adjacent tissue samples.

Collectively, a total of 386 upregulated and 542 downregulated DEGs were identified in NB cell lines. Additionally, MAPK10, DDC, GNG2, PHOX2B, TUBB2B, RASL11B, ITGA2 and ITGA3, which exhibit high connectivity degrees in the PPI networks, may contribute to NB pathogenesis. Furthermore, a novel significant association between the increased expression levels of MAPK10, TUBB2B and RASL11B, and NB was identified.
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![Hierarchical cluster map of DEGs. Horizontal axis indicates the names of each sample, whereas, the right vertical axis indicates clusters of DEGs. Gradual change from blue to orange indicates the expression values, from decreased to increased expression levels. DEGs, differentially expressed genes.](MMR-20-04-3475-g00){#f1-mmr-20-04-3475}

![Top five enriched groups in each functional enrichment analysis. (A) Upregulated DEGs. (B) Downregulated DEGs. MF, molecular function; CC, cellular component; BP, biological process; KEGG, Kyoto Encyclopedia of Genes and Genomes; DEGs, differentially expressed genes; GO, Gene Ontology.](MMR-20-04-3475-g01){#f2-mmr-20-04-3475}

![Protein-protein interaction network of upregulated differentially expressed genes. The top 15 nodes ranked by connectivity degrees are highlighted in blue. Nodes represent genes, and edges connect the nodes to indicate their associations. The node size represents connectivity degree.](MMR-20-04-3475-g02){#f3-mmr-20-04-3475}

![Protein-protein interaction network for downregulated differentially expressed genes. The top 15 nodes ranked by degree values are highlighted in blue. Nodes represent genes, and edges connecting the nodes indicate their associations. The node size represents the respective connectivity degree.](MMR-20-04-3475-g03){#f4-mmr-20-04-3475}

![Result for module analysis. ITGA, integrin subunit α; ITGB, integrin subunit β; COL4A1, collagen type IV α 1 chain; FN1, fibronectin 1; THBS1, thrombospondin 1.](MMR-20-04-3475-g04){#f5-mmr-20-04-3475}

![Integrative regulatory network of TF-targets. The diamond-shaped nodes represent TFs and circles represent target genes. Gray indicates downregulated genes and white indicates upregulated genes. TF, transcription factor.](MMR-20-04-3475-g05){#f6-mmr-20-04-3475}

![RT-qPCR analysis. Relative mRNA expressions of (A) MAPK10, (B) TUBB2B, (C) RASL11B and (D) ITGA2 in the human neuroblastoma SH-SY5Y cell line compared with the hTERT-RPE cell line detected by RT-qPCR. \*\*P\<0.01, \*\*\*P\<0.001 vs. hTERT-RPE cells. RT-qPCR, reverse transcription-quantitative polymerase chain reaction; MAPK10, mitogen-activated protein kinase 10; TUBB2B, tubulin β 2B class IIb; RASL11B, RAS like family 11 member B; ITGA2, integrin subunit α 2.](MMR-20-04-3475-g06){#f7-mmr-20-04-3475}

###### 

Primer sequences for the validated genes.

  Primer name   Primer sequence (5′-3′)
  ------------- --------------------------
  ITGA2-F       GTGGCTTTCCTGAGAACCGA
  ITGA2-R       GATTCCCACATTGCTGTGCC
  MAPK10-F      TGGTGACACGTTATTACAGAGC
  MAPK10-R      GGCCGATTCTCCACATAGTTTCT
  TUBB2B-F      TACTTTAGGTGTGCGCTGGG
  TUBB2B-R      GAGGACACCATTCCGACACA
  RALS11B-F     CGGTTCCTCACCAAACGATTC
  RALS11B-R     GGCTGTTCTCATGGACCTGAA
  GAPDH-F       TGACAACTTTGGTATCGTGGAAGG
  GAPDH-R       AGGCAGGGATGATGTTCTGGAGAG

MAPK10, mitogen-activated protein kinase 10; TUBB2B, tubulin β 2B class IIb; RASL11B, RAS like family 11 member B; ITGA2, integrin subunit α 2; F, forward; R, reverse.

###### 

Top five enriched MF, CC and BP GO terms, and KEGG pathways for upregulated DEGs and downregulated DEGs.

  A, Upregulated DEGs                                                                                                           
  --------------------------- ---------------------------------------------------------------------- ----------- -------------- -------------------------------------------------
  KEGG                        hsa05034:Alcoholism                                                    11          2.84×10^−4^    HIST1H3J, HIST1H3F, HIST2H4A, GNG4 and HIST1H3I
  KEGG                        hsa04728:Dopaminergic synapse                                            9         6.07×10^−4^    DDC, KIF5A, GNG2, MAPK10 and GNG4
  KEGG                        hsa00330:Arginine and proline metabolism                                 6         8.31×10^−4^    CKMT1A, CKMT1B, ARG2, MAOA and ALDH2
  KEGG                        hsa04725:Cholinergic synapse                                             8         1.27×10^−3^    GNAO1, CHRNB4, SLC18A3, GNG2 and CHRNA7
  KEGG                        hsa05032:Morphine addiction                                              7         2.27×10^−3^    GNAO1, PDE3B, PDE10A, GNG2 and GNG4
  MF                          GO:0015276:Ligand-gated ion channel activity                             7         4.32×10^−5^    CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3
  MF                          GO:0042166:Acetylcholine binding                                         6         9.4×10^−5^     CHRNB4, SLC18A3, CHRNA7, CHRNB2 and CHRNA3
  MF                          GO:0004889:Acetylcholine-activated cation-selective channel activity     5         7.32×10^−4^    CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3
  MF                          GO:0015464:Acetylcholine receptor activity                               5         7.32×10^−4^    CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3
  MF                          GO:0008017:Microtubule binding                                         12          1.57×10^−3^    KIF1A, KIF5B, KIF5A, MAPT and KIF5C
  CC                          GO:0030424:Axon                                                        23          1.18×10^−10^   DDC, RET, SYT4, STMN2 and ATL1
  CC                          GO:0043005:Neuron projection                                           23          4.20×10^−10^   CADM1, RAB39B, STMN2, KIF5A and SLC6A2
  CC                          GO:0030054:Cell junction                                               30          6.16×10^−9^    SEPT3, SYT4, GABRB3, GRIK2 and SYP
  CC                          GO:0030426:Growth cone                                                 11          5.07×10^−5^    TSHZ3, STMN2, MAPT, LRRTM1 and STMN4
  CC                          GO:0044295:Axonal growth cone                                            5         2.67×10^−4^    FLRT3, KIF5B, PTCH1, L1CAM and OLFM1
  BP                          GO:0007399:Nervous system development                                  21          6.05×10^−7^    SCN3B, FGF14, DPYSL5, L1CAM and CNTFR
  BP                          GO:0001764:Neuron migration                                            13          7.00×10^−7^    ASCL1, GATA2, PHOX2B, TUBB2B and GATA3
  BP                          GO:0035095:behavioral response to nicotine                               5         1.48×10^−5^    CHRNB4, CHRNA7, CHRNB2, CHRFAM7A and CHRNA3
  BP                          GO:0060384:Innervation                                                   6         1.65×10^−5^    RET, SULF2, GABRB3, RNF165 and ISL1
  BP                          GO:0048485:Sympathetic nervous system development                        5         1.46×10^−4^    PHOX2A, PHOX2B, ASCL1, HAND2 and GATA3
                                                                                                                                
  **B, Downregulated DEGs**                                                                                                     
                                                                                                                                
  **Category**                **Term**                                                               **Count**   **P-value**    **Examples of genes**
                                                                                                                                
  KEGG                        hsa05205:Proteoglycans in cancer                                       27          8.81×10^−10^   ITGA2, ITGB5, CD44, ITGA5 and THBS1
  KEGG                        hsa04512:ECM-receptor interaction                                      17          1.25×10^−8^    COL4A2, COL4A1, ITGA11, ITGA2 and ITGB5
  KEGG                        hsa04510:Focal adhesion                                                25          3.67×10^−8^    ITGA11, ITGA2, ITGB5, ITGA3 and ITGA4
  KEGG                        hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC)        14          3.21×10^−7^    ITGA11, ITGA2, GJA1, ITGB5 and ITGA3
  KEGG                        hsa05410:Hypertrophic cardiomyopathy (HCM)                             14          9.98×10^−7^    IL6, ITGB8, ITGA5, ITGAV and ITGA7
  MF                          GO:0001968:Fibronectin binding                                         11          6.48×10^−10^   CTSK, CTGF, ITGAV, CCDC80 and FSTL3
  MF                          GO:0005518:Collagen binding                                            14          5.31×10^−9^    ADGRG6, ITGA11, ITGA2, SMAD3 and ITGA3
  MF                          GO:0005509:Calcium ion binding                                         49          5.65×10^−9^    LTBP1, LTBP2, LTBP3, FSTL1 and EDIL3
  MF                          GO:0005178:Integrin binding                                            17          2.01×10^−8^    FBN1, ITGA2, ITGA3, EDIL3 and CD151
  MF                          GO:0008201:Heparin binding                                             19          3.16×10^−7^    BMP4, CCL2, LTBP2, LXN and FBN1
  CC                          GO:0009986:Cell surface                                                59          1.21×10^−19^   MICB, MICA, CSPG4, TLR3 and TLR4
  CC                          GO:0005925:Focal adhesion                                              50          1.40×10^−19^   ITGA11, ITGA2, ITGB5, ITGA3 and ITGA4
  CC                          GO:0031012:Extracellular matrix                                        41          2.48×10^−17^   LTBP1, LTBP2, LTBP3, IGFBP7 and POSTNS
  CC                          GO:0005886:Plasma membrane                                             184         4.83×10^−14^   F2RL2, SLC9A7, MICB, MICA and VCL
  CC                          GO:0070062:Extracellular exosome                                       135         4.58×10^−12^   CHMP4C, LTBP2, LTBP3, CSPG4 and FSTL1
  BP                          GO:0007155:Cell adhesion                                               51          6.51×10^−17^   IGFBP7, POSTN, EDIL3, CD151 and VCL
  BP                          GO:0030198:Extracellular matrix organization                           31          2.15×10^−14^   ITGA11, ITGB5, POSTN, ABI3BP and CD44
  BP                          GO:0035987:Endodermal cell differentiation                             13          2.05×10^−12^   HMGA2, COL8A1, MMP14, MMP2 and FN1
  BP                          GO:0010628:Positive regulation of gene expression                      32          8.90×10^−12^   ACTA2, SMAD3, ITGA3, INHBA and TFAP2A
  BP                          GO:0001666:Response to hypoxia                                         23          2.27×10^−9^    MMP14, MMP2, TGFB1, TGFB2 and THBS1

DEGs, differentially expressed genes; MF, molecular function; CC, cellular component; BP, biological process; KEGG, Kyoto Encyclopedia of Genes and Genomes; GO, Gene Ontology.

###### 

Topological property scores for nodes in the protein-protein interaction network, top 20 upregulated DEGs and top 20 downregulated DEGs.

  A, Upregulated DEGs         
  --------------------------- ------------
  GNAO1                       17
  ISL1                        13
  MAPK10                      13
  ASCL1                       13
  RET                         13
  NPY                         12
  TUBB2B                      11
  GNG2                        11
  CHGA                        11
  RASL11B                     10
  GATA3                       10
  PTCH1                         9
  PHOX2B                        9
  DDC                           9
  MAP2                          8
  LGR5                          8
  GATA2                         8
  PHOX2A                        8
  HAND2                         8
  PDE10A                        7
                              
  **B, Downregulated DEGs**   
                              
  **Node**                    **Degree**
                              
  ITGA2                       58
  TGFB1                       58
  MMP2                        55
  IL6                         53
  RAC1                        46
  SMAD3                       44
  ITGB5                       41
  FN1                         40
  THBS1                       39
  BMP4                        35
  SERPINE1                    35
  ITGAV                       34
  EDN1                        32
  CAV1                        32
  CTGF                        31
  ACTA2                       31
  FURIN                       30
  CD44                        28
  MMP14                       27
  MET                         27

DEGs, differentially expressed genes.

###### 

Topological property scores for the top 20 nodes in the TF-target regulatory network.

  A, Upregulated DEGs                           
  --------------------------- ----------------- ------------
  HEY1                        TF                4
  PHOX2B                      TF                2
  HOXC6                       TF                2
                                                
  **B, Downregulated DEGs**                     
                                                
  **Node**                    **Description**   **Degree**
                                                
  TFAP2A                      TF                9
  MITF                        TF                8
  SMAD3                       TF                6
  RUNX1                       TF                5
  PAX6                        TF                5
  AHR                         TF                5
  VDR                         TF                4
  RUNX2                       TF                4
  FOXP2                       TF                4
  FLI1                        TF                4
  MMP2                        Target            3
  MET                         Target            3
  IGFBP3                      Target            3
  IL6                         Target            3
  WWTR1                       TF                2
  OTX2                        TF                2
  NR3C1                       TF                2

TF, transcription factor; DEGs, differentially expressed genes.
